Nov 8

Targeted therapy and radiation synergize in pediatric high-grade glioma

Research at St. Jude recently showed that the drug capmatinib is effective at crossing the blood-brain-barrier, synergizing with radiation to effectively treat pediatric high-grade glioma.

Comments

CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive

Larotrectinib Is Promising for Pediatric TRK Fusion-Positive CNS Tumors

Researchers identify gene signature for high-risk form of T-cell acute lymphoblastic leukemia

If My Dying Daughter Could Face Her Mortality, Why Couldn’t the Rest of Us?

FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer

Cell therapy fights lethal childhood brain cancer in Stanford Medicine trial

Increased Surveillance Recommended for Children at Risk for Hematopoietic Malignancy Predisposition

Targeted therapy and radiation synergize in pediatric high-grade glioma

Even 15 Years Later, Childhood Cancer Survivors More Likely to Develop Leukemia

Recent Posts

Targeted therapy and radiation synergize in pediatric high-grade glioma

Comments

Archive

Search By Tags